Dr Byrd discusses optimizing Ibrutinib & Idela... - CLL Support
Dr Byrd discusses optimizing Ibrutinib & Idelalisib.
You need to be a member of this community to see this post.
5 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Dr. Mato on what really happens when we must stop our ibrutinib or idelalisib
Friends,
I hope my US-based readers had a happy healthy holiday weekend. This past weekend, in...
Dr Sharman's thoughts on the race for FDA Approval for Obinituzumab, Ibrutinib and Idelalisib
Following Gilead's announcement regarding Idelalisib:...
CLL patients with idelalisib (Zydelig) experience
Lymphoma Canada is conducting a survey of CLL patients to appeal to Canadian governments to provide...
Possible side effects from Ibrutinib & Idelalisib
As Ibrutinib and Idelalisib become more widely used among non CLL Specialists I have some concerns...
Dr. Byrd on COVID-19
Hi,
Dr. John Byrd is not only a valued member of our medical advisory board and a world leader in...
Ibrutinib Resistance
